3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
17
Postoperative Complications
1
Pain, Postoperative
1
Implant Capsular Contracture
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Ductal
1
Breast Reconstruction
1
Breast Diseases
1
Breast Carcinoma In Situ
1
Autoimmune Diseases
1
Interventions
Letrozole
5
pyrotinib
4
Trastuzumab
4
Anastrozole
4
palbociclib
3
exemestane
2
abemaciclib
2
Sodium Chloride
2
Exercise
2
Epirubicin
2
Drug Evaluation
2
Docetaxel
2
Cyclophosphamide
2
Botulinum Toxins, Type A
2
Blood Specimen Collection
2
Aromatase Inhibitors
2
sacubitril and valsartan sodium hydrate drug combination
1
ribociclib
1
pertuzumab
1
gadoterate meglumine
1
Vinorelbine
1
Tomography, X-Ray Computed
1
Tamoxifen
1
Surveys and Questionnaires
1
Surgimend
1
Surgical Procedures, Operative
1
Paclitaxel
1
Mammaplasty
1
Liquid Biopsy
1
Leflunomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Breast Diseases
×
Mammaplasty
×
Clear all
NCT02557906
2018-03-13
POBRAD-M
King's College London
Phase NA
Unknown
209 enrolled